patritumab
daiichi sankyo
['patritumab', 'lung', 'breast']
#daiichisankyo reported #patritumabderuxtecan continues to show promising clinical activity in patients across subtypes of #metastatic #breast or #lungcancer #asco22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.